Sponsor:
ECOG-ACRIN Cancer Research Group
Code:
NCT03493425
Conditions
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Carboplatin
Cisplatin
Docetaxel
Image Guided Radiation Therapy
Intensity-Modulated Radiation Therapy
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by ECOG-ACRIN Cancer Research Group on 2025-03-25.